| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-08 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-08 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-07 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-07 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-06 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-06 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.17 | 6e-06 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-06 |